REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) -TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

13/07/2018 11:10

RNS Number : 6005U
Morgan Stanley
13 July 2018
 


 
FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


12 JULY 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES - Shire plc



 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER                            
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



 
Class of relevant security:


 
Ordinary




 
 


Interests


Short positions




Number


%


Number


%




(1) Relevant securities owned and/or controlled:


2,663,963


0.34


7,707,577


0.98




(2) Cash-settled derivatives:
 


7,477,827


0.95


2,311,782


0.29




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:


0


0.00


0


0.00




 
     TOTAL:


10,141,790


1.29


10,019,359


1.27



 
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:


N/A




Details, including nature of the rights concerned and relevant percentages:


N/A



 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


 Purchases/sales


 Total   number of securities


 Highest price per unit paid/received


 Lowest price per unit paid/received




 Ordinary


 PURCHASES


 871,870


 4,663.0000 JPY


 4,556.3791 JPY




 Ordinary


 SALES


 991,418


 4,665.0000 JPY


 4,556.3791 JPY



 
(b)        Cash-settled derivative transactions
 



Class of relevant security


 Product description
            e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per unit




Ordinary


CFD


LONG


100


4646.0000 JPY




Ordinary


CFD


LONG


1100


4659.3745 JPY




Ordinary


CFD


SHORT


1100


4645.2727 JPY




Ordinary


CFD


LONG


1200


4635.8085 JPY




Ordinary


CFD


SHORT


1600


4611.0000 JPY




Ordinary


CFD


SHORT


23100


4586.0000 JPY




Ordinary


CFD


SHORT


13500


4623.9111 JPY




Ordinary


CFD


SHORT


45500


4616.2732 JPY




Ordinary


CFD


SHORT


7100


4617.6338 JPY




Ordinary


CFD


LONG


100


4610.0000 JPY




Ordinary


CFD


SHORT


600


4653.5000 JPY




Ordinary


CFD


LONG


600


4617.6666 JPY




Ordinary


CFD


LONG


100


4628.0000 JPY




Ordinary


CFD


LONG


1600


4628.0000 JPY




Ordinary


CFD


LONG


13700


4633.7006 JPY




Ordinary


CFD


LONG


1600


4628.0000 JPY




Ordinary


CFD


LONG


300


4619.1666 JPY




Ordinary


CFD


LONG


152000


4631.1638 JPY




Ordinary


CFD


SHORT


800


4625.5000 JPY




Ordinary


CFD


SHORT


600


4614.0000 JPY




Ordinary


CFD


LONG


15800


4625.3955 JPY




Ordinary


CFD


SHORT


100


4648.0000 JPY




Ordinary


CFD


SHORT


400


4630.5000 JPY




Ordinary


CFD


SHORT


1500


4611.0000 JPY




Ordinary


CFD


SHORT


300


4628.0000 JPY




Ordinary


CFD


LONG


7700


4628.8961 JPY




Ordinary


CFD


LONG


1600


4649.8125 JPY




Ordinary


CFD


LONG


27000


4635.8085 JPY




Ordinary


CFD


SHORT


3100


4617.8351 JPY




Ordinary


CFD


LONG


100


4612.0000 JPY




Ordinary


CFD


SHORT


13700


4643.3795 JPY




Ordinary


CFD


SHORT


4800


4609.2500 JPY




Ordinary


CFD


LONG


6900


4605.9782 JPY




Ordinary


CFD


SHORT


15600


4608.1153 JPY




Ordinary


CFD


LONG


8000


4618.5500 JPY




Ordinary


CFD


LONG


1422


4556.3791 JPY



 
 
 (c)       Stock-settled derivative transactions (including options)               
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit




N/A


N/A


N/A


N/A


N/A


N/A


N/A


N/A



 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




N/A


N/A


N/A


N/A


N/A



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)




N/A


N/A


N/A


N/A



 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
None
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


NO



 
 



Date of disclosure:


13 JULY 2018




Contact name:


Craig Horsley




Telephone number:


+44(141) 245 7736



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOGGUCUMUPRGUW